Clinical Trial Update: Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR [NA]

View source ↗

Summary

This completed trial compares Genoss DCB with SeQuent Please NEO in Chinese patients with coronary artery disease and in-stent restenosis to evaluate safety and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• In-stent Restenosis

Drugs mentioned

• Genoss DCB (paclitaxel-coated balloon)
• SeQuent Please NEO (paclitaxel-coated balloon)

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: Coronary Artery Disease | NA | Status: COMPLETED